First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT

Autor: Saito, Shigeru a, ∗, Bennett, Johan b, Nef, Holger M. c, Webster, Mark d, Namiki, Atsuo e, Takahashi, Akihiko f, Kakuta, Tsunekazu g, Yamazaki, Seiji h, Shibata, Yoshisato i, Scott, Douglas j, Vrolix, Mathias k, Menon, Madhav l, Möllmann, Helge m, Werner, Nikos n, Neylon, Antoinette o, Mehmedbegovic, Zlatko o, Smits, Pieter C. o, Morice, Marie-Claude o, Verheye, Stefan p
Zdroj: In eClinicalMedicine November 2023 65
Databáze: ScienceDirect